In recent years, GPC-3 and ACTL6A were shown to be new markers for HCC and their over-expressions in HCC were found to be associated with poor survival of the patients (Haruyama & Kataoka, 2016; Xiao et al., 2016). The gene discussed is ACTL6A; the disease is hepatocellular carcinoma.